Biblio
Export 1190 results:
Author Title [ Type] Year Filters: First Letter Of Last Name is D [Clear All Filters]
“Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer's Disease in People with Down Syndrome.”, J Alzheimers Dis, vol. 85, no. 1, pp. 153-165, 2021.
, “Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer's Disease in People with Down Syndrome.”, J Alzheimers Dis, vol. 85, no. 1, pp. 153-165, 2021.
, “Secular Trends in Dementia Prevalence and Incidence Worldwide: A Systematic Review.”, J Alzheimers Dis, vol. 66, no. 2, pp. 653-680, 2018.
, “Salivary Proteomics Reveals Significant Changes in Relation to Alzheimer's Disease and Aging.”, J Alzheimers Dis, vol. 89, no. 2, pp. 605-622, 2022.
, “Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1399-1413, 2022.
, “Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study.”, J Alzheimers Dis, vol. 92, no. 2, pp. 653-665, 2023.
, “The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.”, J Alzheimers Dis, vol. 55, no. 1, pp. 183-197, 2017.
, “Role of Niemann-Pick Type C Disease Mutations in Dementia.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1249-1259, 2017.
, “Role of Niemann-Pick Type C Disease Mutations in Dementia.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1249-1259, 2017.
, “The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 89, no. 3, pp. 1039-1049, 2022.
, “Role of Amyloid-β and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade.”, J Alzheimers Dis, vol. 64, no. s1, pp. S611-S631, 2018.
, “Role of Amyloid-β and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade.”, J Alzheimers Dis, vol. 64, no. s1, pp. S611-S631, 2018.
, “The Role of Amyloid, Tau, and APOE Genotype on the Relationship Between Informant-Reported Sleep Disturbance and Alzheimer's Disease Risks.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1567-1580, 2022.
, “Risk Variants in Three Alzheimer's Disease Genes Show Association with EEG Endophenotypes.”, J Alzheimers Dis, vol. 80, no. 1, pp. 209-223, 2021.
, “Risk Variants in Three Alzheimer's Disease Genes Show Association with EEG Endophenotypes.”, J Alzheimers Dis, vol. 80, no. 1, pp. 209-223, 2021.
, “Risk of Conversion to Dementia in a Mild Behavioral Impairment Group Compared to a Psychiatric Group and to a Mild Cognitive Impairment Group.”, J Alzheimers Dis, vol. 62, no. 1, pp. 227-238, 2018.
, “Risk of Alzheimer's Disease in Obstructive Sleep Apnea Syndrome: Amyloid-β and Tau Imaging.”, J Alzheimers Dis, vol. 66, no. 2, pp. 733-741, 2018.
, “Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 483-493, 2017.
, “Risk Factors Associated with Cortical Thickness and White Matter Hyperintensities in Dementia Free Okinawan Elderly.”, J Alzheimers Dis, vol. 63, no. 1, pp. 365-372, 2018.
, “Risk Assessment of Alzheimer's Disease using the Information Diffusion Model from Structural Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1335-42, 2016.
, “The Right Temporal Variant of Frontotemporal Dementia Is Not Genetically Sporadic: A Case Series.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1195-1201, 2021.
, “The Rhythmicity of Clock Genes is Disrupted in the Choroid Plexus of the APP/PS1 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 77, no. 2, pp. 795-806, 2020.
, “Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 89, no. 3, pp. 943-954, 2022.
, “Rhamnolipids, Microbial Virulence Factors, in Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 1, pp. 209-222, 2017.
, “Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.”, J Alzheimers Dis, vol. 64, no. s1, pp. S47-S105, 2018.
,